Literature DB >> 7780677

Non-steroidal anti-inflammatory drugs and renal function.

P D Delmas1.   

Abstract

The use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with a range of renal effects, including interference with fluid and electrolyte homoeostasis. Common adverse effects are generally mild and transient; less common but more severe effects include reversible renal insufficiency, interstitial nephritis and papillary necrosis. Any of these effects can influence the clinical course of patients at risk because of illness, debility or age. Acute renal failure associated with NSAID use has been reported to account for up to 15.6% of cases of drug-induced renal failure. NSAID-induced haemodynamic renal failure is virtually always reversible with appropriate management; the relatively rare complications of interstitial nephritis and papillary necrosis are more often irreversible. NSAID-related impairment of kidney function is probably due in large part to inhibition of prostaglandin synthesis. Use of a prostaglandin E1 (PGE1) analogue has been suggested to prevent some of the adverse renal effects of NSAIDs in patients at high risk, an interesting possibility that deserves further evaluation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780677     DOI: 10.1093/rheumatology/xxxiv.suppl_1.25

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  5 in total

Review 1.  An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.

Authors:  H Tannenbaum; P Davis; A S Russell; M H Atkinson; W Maksymowych; S H Huang; M Bell; G A Hawker; A Juby; S Vanner; J Sibley
Journal:  CMAJ       Date:  1996-07-01       Impact factor: 8.262

2.  Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis.

Authors:  M Peréz Busquier; E Calero; M Rodríguez; P Castellon Arce; A Bermudez; L F Linares; J Mesa; C Ffernandez Crisostomos; C Garcia; A Garcia Lopez; A Valenzuela; A Povedano; S Garcia Perez; M A Lopez; R Caliz; F Garcia Villalba; M Cano; F Gines Martinez; J Gonzalez; M A Caracuel; R Roldan; M Guzman Ubeda; A Gonzalez; I L Marenco de la Fuente; M Alepuz Pou
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

Review 3.  Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Authors:  G R Matzke; R F Frye
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

4.  Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study.

Authors:  Ylenia Ingrasciotta; Janet Sultana; Francesco Giorgianni; Andrea Fontana; Antonio Santangelo; Daniele Ugo Tari; Domenico Santoro; Vincenzo Arcoraci; Margherita Perrotta; Luisa Ibanez; Gianluca Trifirò
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

Review 5.  Cisplatin-induced renal toxicity in elderly people.

Authors:  ZhiYu Duan; GuangYan Cai; JiJun Li; XiangMei Chen
Journal:  Ther Adv Med Oncol       Date:  2020-05-18       Impact factor: 8.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.